Maravai LifeSciences Holdings Inc

MRVI · NASDAQ

Pharmaceutical Preparation Manufacturing

Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are global leaders in providing products and services into the fields of nucleic acid production, biologics safety testing, and protein detection to many of the world's leading biopharma, vaccine, diagnostics, and cell and gene therapy companies.

Market Data

Price $3.50 -0.13 (-3.58%)

Market Cap—

P/E Ratio—

EPS$—

52W High$—

52W Low$—

Beta—

Data from Finnhub · Updated Mar 11, 2026